Protagonist Therapeutics, Inc. (PTGX) Income Annual - Discounting Cash Flows
PTGX
Protagonist Therapeutics, Inc.
PTGX (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
Report Filing 2025-11-06 2025-02-21 2024-02-27 2023-03-15 2022-02-28 2021-03-10 2020-03-10 2019-03-12 2018-03-07 2017-03-07 2015-12-31 2014-12-31
Revenue 209.2 434.4 60 26.58 27.36 28.63 0.231 30.93 20.06 0 0 0
Cost of Revenue 0 0 0 0 0 0 0 0 0 0.317 0.247 0
Gross Profit 209.2 434.4 60 26.58 27.36 28.63 0.231 30.93 20.06 -0.317 -0.247 0
Operating Expenses 190.2 181.6 153.7 158 153.2 93.14 80.75 73.19 57.96 32.35 14.55 9.32
Research & Development 147.8 138.1 120.2 126.2 126 75.98 65 59.5 46.18 25.7 11.83 7.46
Selling, General and Administrative 42.37 43.46 33.49 31.74 27.2 18.64 15.75 13.7 11.78 6.96 2.96 1.86
Other Operating Expenses 0 0 0 0 0 -1.48 0 0 0 -0.317 -0.247 0
Operating Income 19.01 252.8 -93.65 -131.4 -125.8 -64.52 -80.52 -42.27 -37.9 -32.67 -14.79 -9.32
Net Non-Operating Interest 28.88 26.32 14.9 4.06 0.443 0.302 2.64 2.57 0.948 0.242 0.019 0.016
Interest Income 28.88 26.32 14.9 4.06 0.443 0.9 2.81 2.57 0.948 0.242 0.019 0.016
Interest Expense 0 0 0 0 0 0.598 0.169 0 0 0 0 0
Equity & Other Income/(Expense) 0.182 0.25 -0.201 -0.08 -0.149 -0.631 -0.001 -0.02 -0.008 -4.75 -0.083 -1.77
Income Before Tax 48.07 279.4 -78.95 -127.4 -125.6 -64.84 -77.88 -39.72 -36.96 -37.18 -14.86 -11.07
Income Tax Expense 2.16 4.22 0 0 0 1.3 -0.691 -0.799 0 0 0.064 0
Income Attributable to Non-Controlling Interest 0 0 0 0 0 0 0 0 0 0 -0.064 0
Net Income 45.91 275.2 -78.95 -127.4 -125.6 -66.15 -77.19 -38.92 -36.96 -37.18 -14.86 -11.07
Depreciation and Amortization 1.44 0.826 3.31 3.37 2.77 0.948 0.703 0.527 0.406 0.317 0.247 0.258
EBITDA 20.45 253.7 -90.34 -128 -123.1 -63.57 -79.82 -41.74 -37.49 -32.35 -14.55 -9.06
Earnings Per Share (EPS) 0.75 4.47 -1.39 -2.52 -2.65 -1.92 -2.98 -1.74 -2.09 -5.72 -2.52 -1.88
Diluted Earnings Per Share 0.62 4.23 -1.39 -2.52 -2.65 -1.92 -2.98 -1.74 -2.09 -5.72 -2.52 -1.88
Weighted Average Shares Outstanding 63.77 61.57 56.76 49.04 46.32 34.4 25.89 22.36 17.69 6.5 5.88 5.88
Diluted Weighted Average Shares Outstanding 63.77 65.08 56.76 49.04 46.32 34.4 25.89 22.36 17.69 6.5 5.88 5.88
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program